Table 4.
Population of interest | Comparator population | # of studies | Vaccine uptake likelihood | Strength of evidence | SOE justification | Notes |
---|---|---|---|---|---|---|
Vaccination | ||||||
AA/Black | White | 7 | Less likely | Moderate | --- | Most studies (including the large, good-quality studies), found significantly lower uptake; all general population studies found the same direction of effect |
Latino | 8 | Less likely | Low | Inconsistency | Studies with non-significant differences largely found lower vaccination rates; the 2 largest, good-quality studies found that Latinos were significantly less likely | |
Asian | 2 | Unclear | Insufficient | Inconsistency, imprecision, indirectness | --- | |
AI/AN | 2 | Unclear | Insufficient | Indirectness | --- | |
Pacific Islander | 1 | Unclear | Insufficient | Indirectness | --- | |
Asian/Pacific Islander | 1 | Unclear | Insufficient | Indirectness, imprecision | --- | |
Lower SES (education and/or income) | Higher SES | 4 | Less likely | Low | Inconsistency | --- |
Rural | Urban | 1 | Unclear | Insufficient | Single, small study with multiple limitations | --- |
With disabilities | Without disabilities | 0 | No evidence | --- | --- | --- |
Vaccine intentions | ||||||
AA/Black | White | 4 | No difference | Low | Imprecision | --- |
Latino | 3 | More likely | Low | Inconsistency | --- | |
Lower SES (education and/or income) | Higher SES | 3 | No difference | Low | Unclear precision | --- |
Rural | Urban | 0 | No evidence | --- | --- | --- |
With Disabilities | Without disabilities | 0 | No evidence | --- | --- | --- |
Willingness to take H1N1 vaccine under FDA EUA | ||||||
AA/Black | White | 1 | Unclear | Insufficient | Unclear consistency—one study | --- |
Latino | 1 | Unclear | Insufficient | Unclear consistency—one study | --- | |
Lower SES (education and/or income) | Higher SES | 1 | Unclear | Insufficient | Unclear consistency—one study | --- |
Abbreviations: AA, African American; AI, American Indian; AN, Alaska Native; EUA, Emergency Use Authorization; FDA, Food & Drug Administration; SES, socioeconomic status